Mennemeyer Stephen T

Comparative Cost-effectiveness of Trabeculectomy versus MicroShunt in the US Medicare System.

Trabeculectomy appears to be a dominant treatment strategy over the MicroShunt in the surgical management of glaucoma.

Cost Utility of Schlemm's Canal Microstent Injection With Cataract Surgery for Open-angle Glaucoma in the US Medicare System.

HMS implantation during cataract surgery appears to be cost-effective for patients with mild-to-moderate glaucoma. Nevertheless, more long-term safety and efficacy data are required.

Re: Van Lancker et al.: Clinical outcomes and cost analysis of PreserFlo versus trabeculectomy for glaucoma management in the United Kingdom (Ophthalmol Glaucoma. 2023;6:342-357).

Response to Letter to the Editor: Cost Utility of Schlemm Canal Microstent Injection With Cataract Surgery for Open Angle Glaucoma in the US Medicare System.